You are here

Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Collaborative Neuroscience Network, Inc.
Garden Grove, California, 92845 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Smoking Cessation, Depression
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female cigarette smokers, 18-75 years, motivated to stop smoking and
considered suitable for a smoking cessation attempt

- Smoked an average of at least 10 cigarettes per day during past year and over past
month, and exhaled carbon monoxide (CO) > 10 ppm at screening

- Current or past diagnosis of MDD without psychotic features, either single or
recurrent, using DSM IV TR based on clinical assessment and confirmed by SCID and at
least one of the following:

- On stable antidepressant treatment for MDD (stable dose for at least 2 months)

- Major depressive episode, using DSM IV TR, in the past 2 years successfully treated

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Current or past diagnosis of dementia, schizophrenia, schizoaffective disorder, or
other psychotic disorder, bipolar I disorder, bipolar II disorder.

- Subjects with antisocial, schizotypal, or any other personality disorder severe enough
to compromise the subject's ability to comply with the study requirements..

- Current use of either bupropion or nortryptiline.

NCT01078298
Pfizer
Completed
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Bipolar Disorder, Depression
NCT00939887
All Genders
18+
Years
Multiple Sites
Anxiety Disorders, Depression
NCT00546923
All Genders
Smoking Cessation
NCT00594204
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now